AI Article Synopsis

  • Mesotheliomas often involve disruptions in the Hippo pathway, particularly through mutations in the NF2 gene, leading to increased activation of YAP, a protein that influences gene expression.
  • Research using human mesothelial cells showed that disrupting the Hippo pathway causes changes in cell growth and the development of tumors in mouse models, highlighting the role of activated YAP in these processes.
  • Analysis indicated that the gene PLCB4 is significantly upregulated by YAP, and targeting PLCB4 could offer potential therapeutic options for treating mesothelioma.

Article Abstract

Mesotheliomas are frequently characterized by disruption of Hippo pathway due to deletion and/or mutation in genes, such as neurofibromin 2 ( NF2 ). Hippo disruption attenuates yes-associated protein (YAP) phosphorylation allowing YAP to translocate to the nucleus and regulate gene expression. The role of disrupted Hippo pathway in maintenance of established mesotheliomas has been extensively investigated using cell lines; however, its involvement in development of human mesothelioma has not been explored much. Here, we employed immortalized human mesothelial cells to disrupt Hippo pathway. YAP phosphorylation was reduced on NF2 knockdown and the cells exhibited altered growth in vitro , developing tumors when transplanted into nude mice. Similar results were obtained from enforced expression of wild-type or constitutively active (S127A) YAP, indicating the crucial role of activated YAP in the transformation of mesothelial cells. Gene expression analysis comparing control- and YAP-transduced immortalized human mesothelial cells revealed phospholipase-C beta 4 ( PLCB4 ) to be among the genes highly upregulated by YAP. PLCB4 was upregulated by YAP in immortalized human mesothelial cells and downregulated on YAP knockdown in Hippo-disrupted mesothelioma cell lines. PLCB4 knockdown attenuated the growth of YAP-transduced immortalized mesothelial cells and YAP-active, but not YAP-nonactive, mesothelioma cell lines. Our model system thus provides a versatile tool to investigate the mechanisms underlying mesothelioma development. We suggest that PLCB4 may be an attractive drug target for the treatment of mesothelioma.

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgw084DOI Listing

Publication Analysis

Top Keywords

mesothelial cells
24
human mesothelial
16
mesothelioma cell
12
hippo pathway
12
cell lines
12
immortalized human
12
phospholipase-c beta
8
yap
8
yap phosphorylation
8
gene expression
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!